Search Results

Medical device innovator and worldwide leader in minimally invasive neurosurgery NICO Corporation is launching its latest product innovation at next week’s American Association of Neurosurgical Surgeons Annual Scientific Meeting in Chicago, Booth #825.

The latest product innovation by NICO Corporation is described as a “game-changing advancement” by neurosurgeons with early experience using the NICO Myriad SPECTRA System – the ONLY hand-held technology delivering blue excitation light to enhance tissue fluorescence and assist in the rapidly growing sector of fluorescence-guided surgical removal of grade III and IV glioma brain tumors.

NICO Corporation announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons annual scientific meeting.

NICO Corporation is honored to receive the 2023 Pioneer in Technology Development Award from the Society of Brain Mapping and Therapeutics, a biomedical association founded in 2004 to break boundaries in the areas of brain mapping and intra-operative surgical planning and support trailblazers in science and pioneers in neurotechnology.

NICO Corporation, an Indianapolis-based pioneer and leader in minimally invasive neurosurgery, announced it is among early companies to successfully complete transition to the new European Union Medical Device Regulation.

NICO Corporation, an Indianapolis-based pioneer and leader in minimally invasive neurosurgery, has awarded a $40,000 grant to Daniel Prevedello, MD, vice chair for Academic Affairs and director of Skull Base and Pituitary Surgery Programs at the Ohio State University Comprehensive Cancer Center.

Following the April 22 announcement of the world’s first positive clinical trial for hemorrhagic stroke, trial sponsor NICO Corporation announced that it is infusing another $1 million into its Investigator Initiated Study Grant Program to support further scientific advancements in vascular, tumor, and oncology precision medicine using its novel neurosurgical technologies.

NICO Corporation, a pioneer and leader in minimally invasive neurosurgery, today announced results from the completed ENRICH (Early MiNimally-invasive Removal of ICH) trial will be presented at the annual American Association of Neurological Surgeons (AANS) meeting in Los Angeles from April 21-24.

NICO Corporation has awarded Arabinda Das, PhD, neuroscientist and neuro-oncology assistant professor at the Medical University of South Carolina, a $180,000 Investigator Initiated Study grant supporting the development of a new glioblastoma patient-derived xenograft model.